Analyst consensus rating
Nanobiotix Analyst Rating: Strong Buy
Direct answer
Nanobiotix's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $44.97.
Forecast evidence checked September 16, 2026.
Get free Nanobiotix email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $35.26
- Average price target
- $44.97
- High price target
- $69.61
- Low price target
- $29.52
- Low target gap
- -16.3%
- Target upside
- +27.5%
- High target gap
- +97.4%
- Target range width
- 113.7%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- September 16, 2026
- Valid through
- September 23, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Nanobiotix?
Nanobiotix has a verified Strong Buy consensus. The same dataset has an average price target of $44.97.
How far are Nanobiotix's low and high targets from the recorded price?
The low target implies -16.3%, while the high target implies +97.4%.
How many analysts are included in Nanobiotix's consensus?
The verified consensus includes 3 analysts.
How is Nanobiotix's target upside or downside calculated?
The average target of $44.97 is divided by the recorded price of $35.26, then one is subtracted to produce +27.5%. This does not guarantee a future return.
When was Nanobiotix's analyst forecast verified?
The data was verified on 2026-09-16. The dataset is valid through 2026-09-23.